EE424 Cost-Utility and Budget Impact Analyses of Tumor Necrosis Factor Inhibitor Biologics and Biosimilars Versus Rituximab in Thai Patients with Active Rheumatoid Arthritis
Abstract
Authors
P. Leelahavarong M. Osiri A. Koolvisoot J. Prawjaeng N. Budtarad